A study of nursing patient care in gestational diabetes during SARS CoV-2 pandemic
Keywords:
gestational diabetes mellitus, SARS CoV-2 pandemic, COVID-19 infection, nursing officerAbstract
Although hyperglycaemia that occurs in pregnancy and resolves after birth has been recognised for over fifty years, worldwide consensus on levels of hyperglycaemic thresholds is incomplete and should be diagnosed as 'gestational diabetes mellitus' (GDM). The involvement of GDM is linked to a number of negative perinatal outcomes, including macrosomia, preterm delivery, pre-eclampsia, and eventually will affect the metabolic wellbeing of the resulting infant in future. A nursing care model for non-communicable disorders in primary hospitals increased therapy compliance, as providers aided by clear guidance and administration flowcharts. Early reports from China find COVID-19 infections among men in Wuhan. Later evidence from 30 jurisdictions outside Hubei demonstrated a drop in male domination, as did young women who were diagnosed with the disease at middle age. The psychological and mental health of mothers with GDM has become a big burden with this pandemic in the COVID-19 world-wide that resulted in serious deaths. However, as far as we know, no study explores the success of nurses or licensed clinical nurses during the SARS CoV-2 pandemic in caring for women with GDM.
Downloads
References
Kim Y, Lee JL, Jang IS and Park S (2020) Knowledge and Health Beliefs of Gestational Diabetes Mellitus Associated with Breastfeeding Intention Among Pregnant Women in Bangladesh. Asian Nursing Research 14:144-149. doi: https://doi.org/10.1016/j.anr.2020.06.001
Jesmin S, Akter S, Akashi H, Al-Mamun A, Rahman MA, Islam MM, Sohael F, Okazaki O, Moroi M, Kawano S and Mizutani T (2014) Screening for gestational diabetes mellitus and its prevalence in Bangladesh. Diabetes Research and Clinical Practice 103:57-62. doi: https://doi.org/10.1016/j.diabres.2013.11.024
Guariguata L, Linnenkamp U, Beagley J, Whiting DR and Cho NH (2014) Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 103:176-85. doi: 10.1016/j.diabres.2013.11.003
4. Zhu Y and Zhang C (2016) Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Curr Diab Rep 16:7. doi: 10.1007/s11892-015-0699-x
Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH and Yogev Y (2013) Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 98:4227-49. doi: 10.1210/jc.2013-2465
6International Association of D, Pregnancy Study Groups Consensus P, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva Ad, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJN, Omori Y and Schmidt MI (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care 33:676-682. doi: 10.2337/dc09-1848
American Diabetes A (2013) Standards of medical care in diabetes--2013. Diabetes care 36 Suppl 1:S11-S66. doi: 10.2337/dc13-S011
Bottalico JN (2007) Recurrent gestational diabetes: risk factors, diagnosis, management, and implications. Semin Perinatol 31:176-84. doi: 10.1053/j.semperi.2007.03.006
Kim C, Newton KM and Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862-8. doi: 10.2337/diacare.25.10.1862
(2010) Standards of Medical Care in Diabetes—2010. Diabetes Care 33:S11-S61. doi: 10.2337/dc10-S011
Albareda M, Caballero A, Badell G, Rodríguez-Espinosa J, Ordóñez-Llanos J, de Leiva A and Corcoy R (2005) Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy. Metabolism 54:1115-21. doi: 10.1016/j.metabol.2005.03.017
Mitanchez D, Yzydorczyk C and Simeoni U (2015) What neonatal complications should the pediatrician be aware of in case of maternal gestational diabetes? World J Diabetes 6:734-43. doi: 10.4239/wjd.v6.i5.734
Rafiq W, Hussain SQ, Jan M and Najar BA (2017) Clinical and metabolic profile of neonates of diabetic mothers. 2017 2:5.
Topp CW, Østergaard SD, Søndergaard S and Bech P (2015) The WHO-5 Well-Being Index: A Systematic Review of the Literature. Psychotherapy and Psychosomatics 84:167-176. doi: 10.1159/000376585
Ko JY, Dietz PM, Conrey EJ, Rodgers L, Shellhaas C, Farr SL and Robbins CL (2013) Gestational diabetes mellitus and postpartum care practices of nurse-midwives. J Midwifery Womens Health 58:33-40. doi: 10.1111/j.1542-2011.2012.00261.x
Singh Y, Gupta G, Mishra A, Chellappan DK and Dua K (2020) Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak. Altern Ther Health Med 26:54-55.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia Ja, Yu T, Zhang X and Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 395:507-513. doi: 10.1016/S0140-6736(20)30211-7
Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, Li M, Zheng W, Yi L, Chen X, Wu Q, Liang Y, Wang X, Yang J, Sun K, Longini IM, Jr., Halloran ME, Wu P, Cowling BJ, Merler S, Viboud C, Vespignani A, Ajelli M and Yu H (2020) Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. The Lancet Infectious Diseases 20:793-802. doi: 10.1016/S1473-3099(20)30230-9
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA and Gao YD (2020) Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 75:1730-1741. doi: 10.1111/all.14238
Emami A, Javanmardi F, Pirbonyeh N and Akbari A (2020) Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Archives of academic emergency medicine 8:e35-e35.
Hadden DR (2008) Prediabetes and the big baby. Diabet Med 25:1-10. doi: 10.1111/j.1464-5491.2007.02331.x
Billionnet C, Mitanchez D, Weill A, Nizard J, Alla F, Hartemann A and Jacqueminet S (2017) Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia 60:636-644. doi: 10.1007/s00125-017-4206-6
Ryckman KK, Borowski KS, Parikh NI and Saftlas AF (2013) Pregnancy Complications and the Risk of Metabolic Syndrome for the Offspring. Current Cardiovascular Risk Reports 7:217-223. doi: 10.1007/s12170-013-0308-y
Kim SY, England L, Wilson HG, Bish C, Satten GA and Dietz P (2010) Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity. American Journal of Public Health 100:1047-1052. doi: 10.2105/ajph.2009.172890
McArdle M, Finucane O, Connaughton R, McMorrow A and Roche H (2013) Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional Strategies. Frontiers in Endocrinology 4. doi: 10.3389/fendo.2013.00052
Kern PA, Di Gregorio GB, Lu T, Rassouli N and Ranganathan G (2003) Adiponectin Expression From Human Adipose Tissue. Relation to Obesity, Insulin Resistance, and Tumor Necrosis Factor-α Expression 52:1779-1785. doi: 10.2337/diabetes.52.7.1779
Catalano PM, Tyzbir ED and Sims EA (1990) Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 13:478-82. doi: 10.2337/diacare.13.5.478
Ellard S, Bellanné-Chantelot C and Hattersley AT (2008) Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51:546-53. doi: 10.1007/s00125-008-0942-y
Friedman JE, Ishizuka T, Shao J, Huston L, Highman T and Catalano P (1999) Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 48:1807-14. doi: 10.2337/diabetes.48.9.1807
Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF and Spiegelman BM (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-8. doi: 10.1126/science.271.5249.665
Kirwan JP, Varastehpour A, Jing M, Presley L, Shao J, Friedman JE and Catalano PM (2004) Reversal of insulin resistance postpartum is linked to enhanced skeletal muscle insulin signaling. J Clin Endocrinol Metab 89:4678-84. doi: 10.1210/jc.2004-0749
Singh Y, Gupta G, Satija S, Negi P, Chellappan DK and Dua K (2020) RAAS blockers in hypertension posing a higher risk toward the COVID-19. Dermatol Ther 33:e13501. doi: 10.1111/dth.13501
Singh Y, Gupta G, Kazmi I, Al-Abbasi FA, Negi P, Chellappan DK and Dua K (2020) SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. Dermatol Ther 33:e13871. doi: 10.1111/dth.13871
Vyas G, Mathur M, Patel NA and Patel RP (2017) Aphrodisiac Efficacy of Blepharis sindica seeds: A comparative assessment using different solvent types. Indian journal of biochemistry & biophysics 54:223-230.
Singh Y, Ali H, Alharbi KS, Almalki WH, Kazmi I, Al-Abbasi FA, Anand K, Dureja H, Singh SK, Thangavelu L, Chellappan DK, Dua K and Gupta G Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection. Drug Development Research n/a. doi: https://doi.org/10.1002/ddr.21810
Singh Y, Gupta G, Satija S, Pabreja K, Chellappan DK and Dua K (2020) COVID-19 transmission through host cell directed network of GPCR. Drug Dev Res 81:647-649. doi: 10.1002/ddr.21674
Frydrych LM, Bian G, O'Lone DE, Ward PA and Delano MJ (2018) Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol 104:525-534. doi: 10.1002/jlb.5vmr0118-021rr
Bloomgarden ZT (2020) Diabetes and COVID-19. J Diabetes 12:347-348. doi: 10.1111/1753-0407.13027
Danser AHJ, Epstein M and Batlle D (2020) Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Hypertension 75:1382-1385. doi: 10.1161/hypertensionaha.120.15082
Liu C, Li Y, Guan T, Lai Y, Shen Y, Zeyaweiding A, Zhao H, Li F and Maimaiti T (2018) ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus. Cardiovascular Diabetology 17:127. doi: 10.1186/s12933-018-0771-3
Gupta R, Ghosh A, Singh AK and Misra A (2020) Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr 14:211-212. doi: 10.1016/j.dsx.2020.03.002
Subramanian VB, Katari NK, Ponnam V, Konduru N, Dongala T, Marisetti VM and Vyas G (2022) Stability-indicating reversed-phase-HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness by quality-by-design approach. Biomed Chromatogr 36:e5240. doi: 10.1002/bmc.5240
Valluri V, Katari N, Khatri C, Vyas G, Polagani S and Ponnam V (2021) Highly sensitive liquid chromatography–tandem mass spectrometry assay for the determination of azathioprine in presence of mercaptopurine and its application to a human pharmacokinetic study. Separation Science Plus 4. doi: 10.1002/sscp.202100022
Mundinger MO, Kane RL, Lenz ER, Totten AM, Tsai WY, Cleary PD, Friedewald WT, Siu AL and Shelanski ML (2000) Primary care outcomes in patients treated by nurse practitioners or physicians: a randomized trial. Jama 283:59-68. doi: 10.1001/jama.283.1.59
Horrocks S, Anderson E and Salisbury C (2002) Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors. BMJ 324:819-823. doi: 10.1136/bmj.324.7341.819
Vrijhoef HJ, Diederiks JP, Spreeuwenberg C and Wolffenbuttel BH (2001) Substitution model with central role for nurse specialist is justified in the care for stable type 2 diabetic outpatients. J Adv Nurs 36:546-55. doi: 10.1046/j.1365-2648.2001.02007.x
Puig-Domingo M, Marazuela M and Giustina A (2020) COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 68:2-5. doi: 10.1007/s12020-020-02294-5
Mathur M and Vyas G (2013) Role of nanoparticles for production of smart herbal drug-An overview. Indian Journal of Natural Products and Resources 4:329-338.
Muchakayala SK, Katari NK, Dongala T, Marisetti VM, Vyas G and Vegesna RVK (2022) Eco-friendly and green chromatographic method for the simultaneous determination of chlorocresol and betamethasone dipropionate in topical formulations using Box–Behnken design. Journal of the Iranian Chemical Society 19:1397-1412. doi: 10.1007/s13738-021-02388-5
Nouhjah S, Jahanfar S and Shahbazian H (2020) Temporary changes in clinical guidelines of gestational diabetes screening and management during COVID-19 outbreak: A narrative review. Diabetes & metabolic syndrome 14:939-942. doi: 10.1016/j.dsx.2020.06.030
Ghosh A, Gupta R and Misra A (2020) Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians. Diabetes Metab Syndr 14:273-276. doi: 10.1016/j.dsx.2020.04.001
Poon LC, Yang H, Kapur A, Melamed N, Dao B, Divakar H, McIntyre HD, Kihara AB, Ayres-de-Campos D, Ferrazzi EM, Di Renzo GC and Hod M (2020) Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals. Int J Gynaecol Obstet 149:273-286. doi: 10.1002/ijgo.13156
Hussein J (2020) COVID-19: What implications for sexual and reproductive health and rights globally? Sex Reprod Health Matters 28:1746065. doi: 10.1080/26410397.2020.1746065
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
